Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Argnani, Lisa  [Clear All Filters]
Journal Article
Stefoni V, Argnani L, Carella M, Casadei B, Morigi A, Lolli G, Broccoli A, Pellegrini C, Nanni L, Coppola PElia, et al. BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma: a real-life experience. J Cancer Res Clin Oncol. 2022.
Giladi O, Bagnato G, Gentilini M, Shimony S, Pasvolsky O, Berger T, Itchaki G, Raanani P, Lolli G, Stefoni V, et al. Diffuse large B cell lymphoma characteristics and outcomes during the COVID-19 pandemic in two tertiary centers - an Israeli/ Italian study. Ann Hematol. 2023.
Gentilini M, Casadei B, Broccoli A, Argnani L, Cavo M, Zinzani PLuigi. Elderly Non-GCB Diffuse Large B-Cell Lymphoma Patient Responding to Lenalidomide after Epicardial Relapse: A Case Report. Acta Haematol. 2020:1-4.
Lolli G, Casadei B, Stefoni V, Argnani L, Bonifazi F, Zinzani PLuigi. Hepatosplenic T-cell non-Hodgkin lymphoma cured with tandem autologous and allogeneic stem cell transplantation. Chemotherapy. 2022.
Broccoli A, Argnani L, Zinzani PLuigi. Invited Review: Will Consolidation with ASCT Be a Thing of the Past for MCL and PTCL?. Curr Hematol Malig Rep. 2021.
Casadei B, Argnani L, Morigi A, Lolli G, Broccoli A, Pellegrini C, Nanni L, Stefoni V, Coppola PElia, Carella M, et al. Potential survival benefit for patients receiving autologous hematopoietic stem cell transplantation after checkpoint inhibitors for relapsed/refractory Hodgkin lymphoma: a real-life experience. Hematol Oncol. 2020.
Bagnato G, Stefoni V, Broccoli A, Argnani L, Pellegrini C, Casadei B, Bonifazi F, Zinzani PLuigi. Successful Bridging to Allogeneic Transplantation With Valemetostat in Two Refractory/relapsed Peripheral T-cell lymphoma patients. Mediterr J Hematol Infect Dis. 2024;16(1):e2024004.
Broccoli A, Argnani L, Gugliotta G, Pellegrini C, Casadei B, Bagnato G, Gentilini M, Stefoni V, Zinzani PLuigi. The Treatment of Burkitt Lymphoma With the Berlin-Frankfurt-Münster Protocol With Rituximab and Consolidative Autologous Transplantation. Oncologist. 2024.